1. Home
  2. ACHV vs PACB Comparison

ACHV vs PACB Comparison

Compare ACHV & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$6.80

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

N/A

Current Price

$2.62

Market Cap

655.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACHV
PACB
Founded
N/A
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
726.5M
655.9M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
ACHV
PACB
Price
$6.80
$2.62
Analyst Decision
Strong Buy
Buy
Analyst Count
12
8
Target Price
★ $14.15
$2.54
AVG Volume (30 Days)
1.3M
★ 16.5M
Earning Date
11-13-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $93,468,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.01
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.04
52 Week Low
$2.62
$1.07
52 Week High
$8.64
$3.44

Technical Indicators

Market Signals
Indicator
ACHV
PACB
Relative Strength Index (RSI) 44.06 59.96
Support Level $5.96 $1.24
Resistance Level $7.30 $2.73
Average True Range (ATR) 0.38 0.25
MACD 0.04 0.05
Stochastic Oscillator 43.93 62.82

Price Performance

Historical Comparison
ACHV
PACB

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Share on Social Networks: